Study identifies promising drug target to prevent neurodegenerative conditions
Researchers at University Hospitals Cleveland Medical Center have identified a new drug target that could potentially prevent the progression of neurodegenerative diseases like Parkinson's. This discovery aims to address the underlying causes of neurodegeneration rather than just managing symptoms.
Why it matters
This could lead to disease-modifying treatments for millions of people suffering from incurable neurodegenerative conditions.
Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member Study identifies promising drug target to prevent neurodegenerative conditions Download PDF Copy Add News Medical on Google as a preferred source University Hospitals Cleveland Medical Center Jul 6 2026 Reviewed Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease. Investigators at University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center previously identified a new and promising drug to treat neurodegenerative conditions, including Alzheimer's disease (AD) and traumatic brain injury in a study published in the scientific journal Proceedings of the National Academy of Sciences ( PNAS ).
The article reports on medical research findings without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in